It’s been a busy week in the cannabis realm. A group of scientists is suing the Drug Enforcement Administration (DEA) as they are soliciting a permit to produce cannabis for research purposes; Kyle Jaeger from Marijuana Moment’s reported the House Judiciary Crime, Terrorism, and Homeland Security Subcommittee to hold a hearing to discuss ways to end the cannabis prohibition in the United States next week; New Mexico established its marijuana decriminalization law; and New Jersey extended its medical marijuana program.
As momentum continues on in this booming market, and popular stocks like OrganiGram have reportedly gained record highs of 80.5 percent in the first 6 months of the year, Investors are jumping on the green-rush bandwagon left and right–understandably so.
One forward-thinking company worthy of recognition is Chineseinvestors.com, Inc. (“CIIX”).
CIIX owns and operates www.chineseinvestors.com and www.chineseCBDoil.com, an established financial news and investment portal, and a leading industrial hemp retailer for the Chinese-speaking community with a predominant subscribership based within the United States and Canada.
Offering industrial hemp-derived CBD products, www.chineseCBDoil.com provides a variety of supplements containing hemp-derived CBD, including soft gels, gummies, beauty products, capsules and concentrates, for both English and Chinese-speaking customers, worldwide.
CIIX has also opened a physical store in the predominantly Chinese community of San Gabriel, California, which is also where the Company’s headquarters are located.
Today we’re highlighting: Chineseinvestors.com, Inc. (OTCQB: CIIX), Aurora Cannabis Inc. (NYSE: ACB), Canopy Growth Corporation (NYSE: CGC), Aphria Inc. (NYSE: APHA), and Tilray, Inc. (NASDAQ: TLRY).
Chineseinvestors.com, Inc. (OTCQB: CIIX), (Market Cap: $18.821M; Share Price: $0.40), Chineseinvestors.com, Inc. provides Web-based real-time financial information in Chinese language for the Chinese population in the United States and internationally. The company offers various subscription services, including real-time market commentary and analysis in the Chinese language. The company also provides advisory services on the U.S. capital markets, the U.S. legal system, and the U.S. Securities markets; Website-based advertising services; price chart and news updated on stocks, Website research tools; and additional education services, such as courses offering basic knowledge and practical trading skills. In addition, it offers Website content comprising stock quotes, trading volumes, and pricing indicators for listed companies in the United States. Further, the company sells hemp oil, soft gels, and gummies through its Website, ChineseHempOil.com and Chinese Wellness Center. It provides in person and online courses on crypto currency investment and trading. The company offers its services through its Websites, as well as through customer support personnel at its telemarketing and customer service center.
Aurora Cannabis Inc. (NYSE: ACB), (Market Cap: $7.412B); (Share Price: $7.36), Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company’s products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. The company has operations in 24 countries across five continents. Aurora Cannabis has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies.
Canopy Growth Corporation (NYSE: CGC), (Market Cap: $13.555B); (Share Price: $39.39), Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs.
Aphria Inc. (NYSE: APHA), (Market Cap: $1.686B); (Share Price: $6.78), Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market.
The company announced on July 8th the launch of its new social impact platform, Plant Positivity. Championing the incredible power that plants have in overall well-being and providing greater access to green spaces for communities, Plant Positivity will be a new component of Aphria’s existing Corporate Social Responsibility strategy, which will continue to deliver on the Company’s commitment to give back to both people and the planet. The platform will be brought to life through three interconnected pillars – Plant Education, Plant Access, and Plant Impact.
Tilray, Inc. (NASDAQ: TLRY), (Market Cap: $4.388B); (Share Price: $45.13), Tilray engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, and compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, the United Kingdom, the United States, and South Africa.
Provided that the United States is the global marijuana front-runner, with a Chinese-American population nearing 3.8 million, CIIX is a company worth watching as they cater to a niche demographic which will undoubtedly build brand loyalty and recurring customers for years to come.
This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a six month term consulting agreement with CIIX dated 6/20/2019. The agreement calls for $20,000 in cash, and 30,000 restricted 144 shares of CIIX per month. All payments were made directly by ChineseInvestors.com, Inc. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting has a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. CIIX was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.
Company Name: ACR Communication LLC.
Contact Person: Media Manager
Country: United States